Tanabe Pharma Corporation sues Lupin Limited and others in civil action
Case Summary
Tanabe Pharma Corporation filed suit against Lupin Limited and others. No further case details or summaries are available under docket 25-cv-16680.
No timeline activity recorded yet. This page will grow as rulings and filings land.
Key Issues
- • pharmaceutical litigation
- • pending case
- • lack of details
Docket Snapshot
Court
Court not identified
Awaiting court metadata
Docket
Not captured
Civil
Stage
Active litigation
Active
Filed
Date unavailable
Not in the available feed
Latest Filing
2:25-cv-16680 TANABE PHARMA CORPORATION v. LUPIN LIMITED et al
Other · Apr 25, 2026
Coverage
1 article
1 source tracked
Participants
1 Defendant, 1 Plaintiff
2 linked entities
Judge
Not assigned in feed
What the record shows
The court metadata has not been resolved yet, so Juryvine is keeping the page conservative until a reliable court match lands.
The newest docket activity we have is a other dated April 25, 2026.
The visible party/entity graph currently includes Lupin Limited, Tanabe Pharma Corporation.
Press monitoring has found 1 related article from 1 distinct source.
The Story So Far
TANABE PHARMA CORPORATION v. LUPIN LIMITED et al is an active civil matter under docket 25-cv-16680.
The dispute currently identifies 2:25-cv-16680 TANABE PHARMA CORPORATION on one side and LUPIN LIMITED on the other. The case is currently organized around Current docket activity and next procedural step, Real-estate, land-use, or property disputes, Federal jurisdiction and procedural posture, Intellectual-property ownership and infringement.
The available docket gives enough signal to track the case, but not enough to overstate the merits. This page will become more useful as filings, orders, hearings, and party appearances add detail.
On April 25, 2026, the docket recorded a other: The court granted Tanabe Pharma Corporation's motion to seal certain documents in the case against Lupin Limited and others. This decision allows Tanabe Pharma to keep sensitive information confidential. The ruling is significant because it sets a precedent.
The next thing to watch is whether the latest other produces a substantive order, a scheduling change, a settlement signal, or a filing that clarifies the parties' positions.
Case Timeline
1 event2:25-cv-16680 TANABE PHARMA CORPORATION v. LUPIN LIMITED et al
The court granted Tanabe Pharma Corporation's motion to seal certain documents in the case against Lupin Limited and others. This decision allows Tanabe Pharma to keep sensitive information confidential. The ruling is significant because it sets a precedent for future cases involving trade secrets and intellectual property.
Press Coverage
settings_backup_restore Data provenance expand_more
Sources tracked
1 outlet · 1 article
Timeline events
1 record on file
Last updated
2 days, 8 hours ago
Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.